来源
2007-12-28 9:30:52

Nature子刊:三篇文章鉴别可拓展“核染质编码”两种新变异

生物谷综合报道:核染质是构成染色体的DNA和蛋白质的一个组分。在12月在线出版的《自然—细胞生物学》期刊上,三篇论文对核染质进行了分析,鉴别出可拓展“核染质编码”的两种新变异。研究人员还发现,核染质的一种变异调控了“后生记忆”,这是克隆过程中一个非常关键的步骤。

人类的DNA分子总共有2米长。为了防止长长的DNA分子处于混乱状态,基因组紧紧地缠在一种名为组蛋白的蛋白质复合体上。最近的研究发现,组蛋白质也参与了基因活性的调控,这些蛋白质的大量可逆转化学修饰也被揭示出来,它们也能调控基因的表达。

在核染质密码的周期表中,Roland  Schüle和同事鉴别出一种名为磷酸化组蛋白的新元素H3,并发现这种元素让包裹在磷酸化H3中的基因变得活跃。 

Pax7是调控肌肉基因活性的一个关键因子。在一篇相关的论文中,Michael  Rudnicki和同事揭示出Pax7的工作原理。通过将一种附加到甲基组团的酶与H3结合,它能调控某种控制干细胞分化成肌肉细胞的基因。

最后,John  Gurdon和同事发现了一种基因在克隆过程中是如何保持自己的活跃状态。这种基因状态的记忆依赖于H3的特别变异H3.3。最令人吃惊的是,这种记忆可一直保持到受精卵细胞的第24次分裂增生。

生物谷推荐英文原文

英文原文一:

Nature Cell Biology

Published online: 9 December 2007; | doi:10.1038/ncb1668

Phosphorylation of histone H3 at threonine 11 establishes a novel chromatin mark for transcriptional regulation

Eric Metzger1, Na Yin1, Melanie Wissmann1, Natalia Kunowska1, Kristin Fischer1, Nicolaus Friedrichs2, Debasis Patnaik3, Jonathan M. G. Higgins3, Noelle Potier4, Karl-Heinz Scheidtmann5, Reinhard Buettner2 & Roland Schüle1

1  Universitäts-Frauenklinik und Zentrale Klinische Forschung, Klinikum der Universität Freiburg, Breisacherstrasse 66, 79106 Freiburg, Germany.

2  Institut für Pathologie, Universitätsklinikum Bonn, Sigmund-Freud-Strasse 25, 53127 Bonn, Germany.

3  Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

4  Institut de Chimie LC3 – CNRS - UMR 7177, ISIS, 8 allée Gaspard Monge, 67083 Strasbourg, France.

5  Institut für Genetik, Universität Bonn, Römerstrasse 16, 53117 Bonn, Germany.

Correspondence should be addressed to Roland Schüle roland.schuele@uniklinik-freiburg.de

Posttranslational modifications of histones such as methylation, acetylation and phosphorylation regulate chromatin structure and gene expression. Here we show that protein-kinase-C-related kinase 1 (PRK1) phosphorylates histone H3 at threonine 11 (H3T11) upon ligand-dependent recruitment to androgen receptor target genes. PRK1 is pivotal to androgen receptor function because PRK1 knockdown or inhibition impedes androgen receptor-dependent transcription. Blocking PRK1 function abrogates androgen-induced H3T11 phosphorylation and inhibits androgen-induced demethylation of histone H3. Moreover, serine-5-phosphorylated RNA polymerase II is no longer observed at androgen receptor target promoters. Phosphorylation of H3T11 by PRK1 accelerates demethylation by the Jumonji C (JmjC)-domain-containing protein JMJD2C. Thus, phosphorylation of H3T11 by PRK1 establishes a novel chromatin mark for gene activation, identifying PRK1 as a gatekeeper of androgen receptor-dependent transcription. Importantly, levels of PRK1 and phosphorylated H3T11 correlate with Gleason scores of prostate carcinomas. Finally, inhibition of PRK1 blocks proliferation of androgen receptor-induced tumour cell proliferation, making PRK1 a promising therapeutic target.

[1] [2] 下一页

  • 众说风云 (已有1条评论)

聚焦

二十年英杰在整合中前行!

Invitrogen董事长兼CEO:Gregory Lucier先生专访

Master

人物

成功的秘诀

Train to gain

招聘

为你的职业拓宽道路

分子生物学相关产品



定量PCR仪

Eppendorf Ep Master
定量PCR仪

实时定量PCR仪

ABI Stepone TM 实时定量PCR仪,最新的软件系统,界面友好,操作简单

PCR产物纯化

各种厂家和各种规格的PCR产物纯化试剂盒


定量PCR试剂

最全的定量PCR试剂


荧光定量PCR全套服务方案

从引物设计到实验全程服务